US2020306265A1PendingUtilityA1
Neuroactive steroids, compositions, and uses thereof
Est. expiryMar 8, 2036(~9.6 yrs left)· nominal 20-yr term from priority
A61K 31/57A61P 25/14A61K 31/573A61P 25/24A61P 25/22A61P 15/00A61K 31/58A61K 47/40A61K 31/56A61K 9/08A61K 31/568A61K 9/0019
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Described herein are methods of treating a disorder, e.g., tremor, e.g., essential tremor; depression, e.g., postpartum depression; and anxiety disorder, the method comprising administering to a human subject suffering from a disorder, e.g., tremor, e.g., essential tremor, depression, e.g., postpartum depression, an anxiety disorder with a neuroactive steroid or a composition comprising a neuroactive steroid (e.g., pregnanolone, allopregnanolone, alphadalone, ganaxolone, or alphaxolone).
Claims
exact text as granted — not AI-modified1 - 65 . (canceled)
66 . A method of treating a human subject suffering from depression or an anxiety disorder, comprising administering to the subject a therapeutically effective amount of a compound of the formulaJoin the waitlist — get patent alerts
Track US2020306265A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.